- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
According to our latest study, the global Argatroban market size was valued at USD 65 million in 2022 and is forecast to a readjusted size of USD 44 million by 2029 with a CAGR of -5.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Argatroban key players include Mitsubishi Tanabe Pharma, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, SANDOZ, etc. Global top four manufacturers hold a share nearly 60%.
Japan is the largest market, with a share about 35%, followed by Europe, and USA, both have a share about 55 percent.
In terms of product, Argatroban Injection is the largest segment, with a share over 70%. And in terms of application, the largest application is Heparin-induced thrombocytopenia (HIT), followed by Percutaneous Coronary Intervention, Cerebral arterial thrombosis.
This report is a detailed and comprehensive analysis for global Argatroban market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Argatroban market size and forecasts, in consumption value ($ Million), sales quantity (g), and average selling prices (USD/g), 2018-2029
Global Argatroban market size and forecasts by region and country, in consumption value ($ Million), sales quantity (g), and average selling prices (USD/g), 2018-2029
Global Argatroban market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (g), and average selling prices (USD/g), 2018-2029
Global Argatroban market shares of main players, shipments in revenue ($ Million), sales quantity (g), and ASP (USD/g), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Argatroban
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Argatroban market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Inc, SANDOZ, GlaxoSmithKline Plc, fresenius-kabi and Eagle Pharmaceuticals, Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Argatroban market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Argatroban Powder
Argatroban Injection
Market segment by Application
Heparin-induced Thrombocytopenia (HIT)
Percutaneous Coronary Intervention
Cerebral Arterial Thrombosis
Major players covered
Pfizer, Inc
SANDOZ
GlaxoSmithKline Plc
fresenius-kabi
Eagle Pharmaceuticals, Inc
Mitsubishi Tanabe Pharma
Teva Pharmaceutical Industries Ltd
WEST-WARD,INC
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Argatroban product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Argatroban, with price, sales, revenue and global market share of Argatroban from 2018 to 2023.
Chapter 3, the Argatroban competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Argatroban breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Argatroban market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Argatroban.
Chapter 14 and 15, to describe Argatroban sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Argatroban
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Argatroban Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Argatroban Powder
1.3.3 Argatroban Injection
1.4 Market Analysis by Application
1.4.1 Overview: Global Argatroban Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Heparin-induced Thrombocytopenia (HIT)
1.4.3 Percutaneous Coronary Intervention
1.4.4 Cerebral Arterial Thrombosis
1.5 Global Argatroban Market Size & Forecast
1.5.1 Global Argatroban Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Argatroban Sales Quantity (2018-2029)
1.5.3 Global Argatroban Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Pfizer, Inc
2.1.1 Pfizer, Inc Details
2.1.2 Pfizer, Inc Major Business
2.1.3 Pfizer, Inc Argatroban Product and Services
2.1.4 Pfizer, Inc Argatroban Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer, Inc Recent Developments/Updates
2.2 SANDOZ
2.2.1 SANDOZ Details
2.2.2 SANDOZ Major Business
2.2.3 SANDOZ Argatroban Product and Services
2.2.4 SANDOZ Argatroban Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 SANDOZ Recent Developments/Updates
2.3 GlaxoSmithKline Plc
2.3.1 GlaxoSmithKline Plc Details
2.3.2 GlaxoSmithKline Plc Major Business
2.3.3 GlaxoSmithKline Plc Argatroban Product and Services
2.3.4 GlaxoSmithKline Plc Argatroban Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GlaxoSmithKline Plc Recent Developments/Updates
2.4 fresenius-kabi
2.4.1 fresenius-kabi Details
2.4.2 fresenius-kabi Major Business
2.4.3 fresenius-kabi Argatroban Product and Services
2.4.4 fresenius-kabi Argatroban Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 fresenius-kabi Recent Developments/Updates
2.5 Eagle Pharmaceuticals, Inc
2.5.1 Eagle Pharmaceuticals, Inc Details
2.5.2 Eagle Pharmaceuticals, Inc Major Business
2.5.3 Eagle Pharmaceuticals, Inc Argatroban Product and Services
2.5.4 Eagle Pharmaceuticals, Inc Argatroban Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Eagle Pharmaceuticals, Inc Recent Developments/Updates
2.6 Mitsubishi Tanabe Pharma
2.6.1 Mitsubishi Tanabe Pharma Details
2.6.2 Mitsubishi Tanabe Pharma Major Business
2.6.3 Mitsubishi Tanabe Pharma Argatroban Product and Services
2.6.4 Mitsubishi Tanabe Pharma Argatroban Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
2.7 Teva Pharmaceutical Industries Ltd
2.7.1 Teva Pharmaceutical Industries Ltd Details
2.7.2 Teva Pharmaceutical Industries Ltd Major Business
2.7.3 Teva Pharmaceutical Industries Ltd Argatroban Product and Services
2.7.4 Teva Pharmaceutical Industries Ltd Argatroban Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
2.8 WEST-WARD,INC
2.8.1 WEST-WARD,INC Details
2.8.2 WEST-WARD,INC Major Business
2.8.3 WEST-WARD,INC Argatroban Product and Services
2.8.4 WEST-WARD,INC Argatroban Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 WEST-WARD,INC Recent Developments/Updates
3 Competitive Environment: Argatroban by Manufacturer
3.1 Global Argatroban Sales Quantity by Manufacturer (2018-2023)
3.2 Global Argatroban Revenue by Manufacturer (2018-2023)
3.3 Global Argatroban Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Argatroban by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Argatroban Manufacturer Market Share in 2022
3.4.2 Top 6 Argatroban Manufacturer Market Share in 2022
3.5 Argatroban Market: Overall Company Footprint Analysis
3.5.1 Argatroban Market: Region Footprint
3.5.2 Argatroban Market: Company Product Type Footprint
3.5.3 Argatroban Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Argatroban Market Size by Region
4.1.1 Global Argatroban Sales Quantity by Region (2018-2029)
4.1.2 Global Argatroban Consumption Value by Region (2018-2029)
4.1.3 Global Argatroban Average Price by Region (2018-2029)
4.2 North America Argatroban Consumption Value (2018-2029)
4.3 Europe Argatroban Consumption Value (2018-2029)
4.4 Asia-Pacific Argatroban Consumption Value (2018-2029)
4.5 South America Argatroban Consumption Value (2018-2029)
4.6 Middle East and Africa Argatroban Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Argatroban Sales Quantity by Type (2018-2029)
5.2 Global Argatroban Consumption Value by Type (2018-2029)
5.3 Global Argatroban Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Argatroban Sales Quantity by Application (2018-2029)
6.2 Global Argatroban Consumption Value by Application (2018-2029)
6.3 Global Argatroban Average Price by Application (2018-2029)
7 North America
7.1 North America Argatroban Sales Quantity by Type (2018-2029)
7.2 North America Argatroban Sales Quantity by Application (2018-2029)
7.3 North America Argatroban Market Size by Country
7.3.1 North America Argatroban Sales Quantity by Country (2018-2029)
7.3.2 North America Argatroban Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Argatroban Sales Quantity by Type (2018-2029)
8.2 Europe Argatroban Sales Quantity by Application (2018-2029)
8.3 Europe Argatroban Market Size by Country
8.3.1 Europe Argatroban Sales Quantity by Country (2018-2029)
8.3.2 Europe Argatroban Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Argatroban Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Argatroban Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Argatroban Market Size by Region
9.3.1 Asia-Pacific Argatroban Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Argatroban Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Argatroban Sales Quantity by Type (2018-2029)
10.2 South America Argatroban Sales Quantity by Application (2018-2029)
10.3 South America Argatroban Market Size by Country
10.3.1 South America Argatroban Sales Quantity by Country (2018-2029)
10.3.2 South America Argatroban Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Argatroban Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Argatroban Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Argatroban Market Size by Country
11.3.1 Middle East & Africa Argatroban Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Argatroban Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Argatroban Market Drivers
12.2 Argatroban Market Restraints
12.3 Argatroban Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Argatroban and Key Manufacturers
13.2 Manufacturing Costs Percentage of Argatroban
13.3 Argatroban Production Process
13.4 Argatroban Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Argatroban Typical Distributors
14.3 Argatroban Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Argatroban Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Argatroban Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer, Inc Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer, Inc Major Business
Table 5. Pfizer, Inc Argatroban Product and Services
Table 6. Pfizer, Inc Argatroban Sales Quantity (g), Average Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer, Inc Recent Developments/Updates
Table 8. SANDOZ Basic Information, Manufacturing Base and Competitors
Table 9. SANDOZ Major Business
Table 10. SANDOZ Argatroban Product and Services
Table 11. SANDOZ Argatroban Sales Quantity (g), Average Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. SANDOZ Recent Developments/Updates
Table 13. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 14. GlaxoSmithKline Plc Major Business
Table 15. GlaxoSmithKline Plc Argatroban Product and Services
Table 16. GlaxoSmithKline Plc Argatroban Sales Quantity (g), Average Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GlaxoSmithKline Plc Recent Developments/Updates
Table 18. fresenius-kabi Basic Information, Manufacturing Base and Competitors
Table 19. fresenius-kabi Major Business
Table 20. fresenius-kabi Argatroban Product and Services
Table 21. fresenius-kabi Argatroban Sales Quantity (g), Average Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. fresenius-kabi Recent Developments/Updates
Table 23. Eagle Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
Table 24. Eagle Pharmaceuticals, Inc Major Business
Table 25. Eagle Pharmaceuticals, Inc Argatroban Product and Services
Table 26. Eagle Pharmaceuticals, Inc Argatroban Sales Quantity (g), Average Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Eagle Pharmaceuticals, Inc Recent Developments/Updates
Table 28. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 29. Mitsubishi Tanabe Pharma Major Business
Table 30. Mitsubishi Tanabe Pharma Argatroban Product and Services
Table 31. Mitsubishi Tanabe Pharma Argatroban Sales Quantity (g), Average Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 33. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 34. Teva Pharmaceutical Industries Ltd Major Business
Table 35. Teva Pharmaceutical Industries Ltd Argatroban Product and Services
Table 36. Teva Pharmaceutical Industries Ltd Argatroban Sales Quantity (g), Average Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 38. WEST-WARD,INC Basic Information, Manufacturing Base and Competitors
Table 39. WEST-WARD,INC Major Business
Table 40. WEST-WARD,INC Argatroban Product and Services
Table 41. WEST-WARD,INC Argatroban Sales Quantity (g), Average Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. WEST-WARD,INC Recent Developments/Updates
Table 43. Global Argatroban Sales Quantity by Manufacturer (2018-2023) & (g)
Table 44. Global Argatroban Revenue by Manufacturer (2018-2023) & (USD Million)
Table 45. Global Argatroban Average Price by Manufacturer (2018-2023) & (USD/g)
Table 46. Market Position of Manufacturers in Argatroban, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 47. Head Office and Argatroban Production Site of Key Manufacturer
Table 48. Argatroban Market: Company Product Type Footprint
Table 49. Argatroban Market: Company Product Application Footprint
Table 50. Argatroban New Market Entrants and Barriers to Market Entry
Table 51. Argatroban Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Argatroban Sales Quantity by Region (2018-2023) & (g)
Table 53. Global Argatroban Sales Quantity by Region (2024-2029) & (g)
Table 54. Global Argatroban Consumption Value by Region (2018-2023) & (USD Million)
Table 55. Global Argatroban Consumption Value by Region (2024-2029) & (USD Million)
Table 56. Global Argatroban Average Price by Region (2018-2023) & (USD/g)
Table 57. Global Argatroban Average Price by Region (2024-2029) & (USD/g)
Table 58. Global Argatroban Sales Quantity by Type (2018-2023) & (g)
Table 59. Global Argatroban Sales Quantity by Type (2024-2029) & (g)
Table 60. Global Argatroban Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Global Argatroban Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Global Argatroban Average Price by Type (2018-2023) & (USD/g)
Table 63. Global Argatroban Average Price by Type (2024-2029) & (USD/g)
Table 64. Global Argatroban Sales Quantity by Application (2018-2023) & (g)
Table 65. Global Argatroban Sales Quantity by Application (2024-2029) & (g)
Table 66. Global Argatroban Consumption Value by Application (2018-2023) & (USD Million)
Table 67. Global Argatroban Consumption Value by Application (2024-2029) & (USD Million)
Table 68. Global Argatroban Average Price by Application (2018-2023) & (USD/g)
Table 69. Global Argatroban Average Price by Application (2024-2029) & (USD/g)
Table 70. North America Argatroban Sales Quantity by Type (2018-2023) & (g)
Table 71. North America Argatroban Sales Quantity by Type (2024-2029) & (g)
Table 72. North America Argatroban Sales Quantity by Application (2018-2023) & (g)
Table 73. North America Argatroban Sales Quantity by Application (2024-2029) & (g)
Table 74. North America Argatroban Sales Quantity by Country (2018-2023) & (g)
Table 75. North America Argatroban Sales Quantity by Country (2024-2029) & (g)
Table 76. North America Argatroban Consumption Value by Country (2018-2023) & (USD Million)
Table 77. North America Argatroban Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Europe Argatroban Sales Quantity by Type (2018-2023) & (g)
Table 79. Europe Argatroban Sales Quantity by Type (2024-2029) & (g)
Table 80. Europe Argatroban Sales Quantity by Application (2018-2023) & (g)
Table 81. Europe Argatroban Sales Quantity by Application (2024-2029) & (g)
Table 82. Europe Argatroban Sales Quantity by Country (2018-2023) & (g)
Table 83. Europe Argatroban Sales Quantity by Country (2024-2029) & (g)
Table 84. Europe Argatroban Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Argatroban Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Argatroban Sales Quantity by Type (2018-2023) & (g)
Table 87. Asia-Pacific Argatroban Sales Quantity by Type (2024-2029) & (g)
Table 88. Asia-Pacific Argatroban Sales Quantity by Application (2018-2023) & (g)
Table 89. Asia-Pacific Argatroban Sales Quantity by Application (2024-2029) & (g)
Table 90. Asia-Pacific Argatroban Sales Quantity by Region (2018-2023) & (g)
Table 91. Asia-Pacific Argatroban Sales Quantity by Region (2024-2029) & (g)
Table 92. Asia-Pacific Argatroban Consumption Value by Region (2018-2023) & (USD Million)
Table 93. Asia-Pacific Argatroban Consumption Value by Region (2024-2029) & (USD Million)
Table 94. South America Argatroban Sales Quantity by Type (2018-2023) & (g)
Table 95. South America Argatroban Sales Quantity by Type (2024-2029) & (g)
Table 96. South America Argatroban Sales Quantity by Application (2018-2023) & (g)
Table 97. South America Argatroban Sales Quantity by Application (2024-2029) & (g)
Table 98. South America Argatroban Sales Quantity by Country (2018-2023) & (g)
Table 99. South America Argatroban Sales Quantity by Country (2024-2029) & (g)
Table 100. South America Argatroban Consumption Value by Country (2018-2023) & (USD Million)
Table 101. South America Argatroban Consumption Value by Country (2024-2029) & (USD Million)
Table 102. Middle East & Africa Argatroban Sales Quantity by Type (2018-2023) & (g)
Table 103. Middle East & Africa Argatroban Sales Quantity by Type (2024-2029) & (g)
Table 104. Middle East & Africa Argatroban Sales Quantity by Application (2018-2023) & (g)
Table 105. Middle East & Africa Argatroban Sales Quantity by Application (2024-2029) & (g)
Table 106. Middle East & Africa Argatroban Sales Quantity by Region (2018-2023) & (g)
Table 107. Middle East & Africa Argatroban Sales Quantity by Region (2024-2029) & (g)
Table 108. Middle East & Africa Argatroban Consumption Value by Region (2018-2023) & (USD Million)
Table 109. Middle East & Africa Argatroban Consumption Value by Region (2024-2029) & (USD Million)
Table 110. Argatroban Raw Material
Table 111. Key Manufacturers of Argatroban Raw Materials
Table 112. Argatroban Typical Distributors
Table 113. Argatroban Typical Customers
List of Figures
Figure 1. Argatroban Picture
Figure 2. Global Argatroban Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Argatroban Consumption Value Market Share by Type in 2022
Figure 4. Argatroban Powder Examples
Figure 5. Argatroban Injection Examples
Figure 6. Global Argatroban Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Argatroban Consumption Value Market Share by Application in 2022
Figure 8. Heparin-induced Thrombocytopenia (HIT) Examples
Figure 9. Percutaneous Coronary Intervention Examples
Figure 10. Cerebral Arterial Thrombosis Examples
Figure 11. Global Argatroban Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Argatroban Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Argatroban Sales Quantity (2018-2029) & (g)
Figure 14. Global Argatroban Average Price (2018-2029) & (USD/g)
Figure 15. Global Argatroban Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Argatroban Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Argatroban by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Argatroban Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Argatroban Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Argatroban Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Argatroban Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Argatroban Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Argatroban Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Argatroban Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Argatroban Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Argatroban Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Argatroban Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Argatroban Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Argatroban Average Price by Type (2018-2029) & (USD/g)
Figure 30. Global Argatroban Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Argatroban Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Argatroban Average Price by Application (2018-2029) & (USD/g)
Figure 33. North America Argatroban Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Argatroban Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Argatroban Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Argatroban Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Argatroban Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Argatroban Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Argatroban Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Argatroban Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Argatroban Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Argatroban Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Argatroban Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Argatroban Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Argatroban Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Argatroban Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Argatroban Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Argatroban Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Argatroban Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Argatroban Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Argatroban Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Argatroban Consumption Value Market Share by Region (2018-2029)
Figure 53. China Argatroban Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Argatroban Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Argatroban Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Argatroban Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Argatroban Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Argatroban Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Argatroban Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Argatroban Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Argatroban Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Argatroban Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Argatroban Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Argatroban Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Argatroban Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Argatroban Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Argatroban Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Argatroban Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Argatroban Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Argatroban Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Argatroban Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Argatroban Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Argatroban Market Drivers
Figure 74. Argatroban Market Restraints
Figure 75. Argatroban Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Argatroban in 2022
Figure 78. Manufacturing Process Analysis of Argatroban
Figure 79. Argatroban Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
